Get access to our best features
Get access to our best features
Published 2 months ago

Ibogaine, the psychedelic, unlikely to receive approval as opioid treatment, says top addiction researcher

Summary by Ground News
The remarks come from Nora Volkow, the longtime director of the National Institute on Drug Abuse. ibogaine is a naturally occurring substance that drug companies and researchers have increasingly cast as a potential paradigm-shifting addiction treatment. Its potential cardiac side effects could stand in the way of receiving approval from the Food and Drug Administration.

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)